SCHEMBL5197842

SCHEMBL5197842

Cc1cccc(-c2n[nH]cc2-c2ccc(F)c(-c3c[nH]c(CO)n3)c2)n1

nearest known ligand 0.41

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
TGFBR1 P36897 17/20 0.41
MAPK14 Q16539 5/20 0.35
THRB P10828 1/20 0.34
CYP1A2 P05177 1/20 0.32
CYP2D6 P10635 1/20 0.32
CYP2C9 P11712 1/20 0.32
CYP2C19 P33261 1/20 0.32
MEN1 O00255 1/20 0.32
NPC1 O15118 1/20 0.32
CASP3 P42574 1/20 0.32
RAB9A P51151 1/20 0.32
KMT2A Q03164 1/20 0.32
ATM Q13315 1/20 0.32
SENP8 Q96LD8 1/20 0.32
SENP7 Q9BQF6 1/20 0.32
SENP6 Q9GZR1 1/20 0.32
PAK1 Q13153 1/20 0.31
TRPV3 Q8NET8 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5199574 0.92 TGFBR1 (0.41) TGFBR1MAPK14THRBCYP1A2CYP2D6
SCHEMBL5199422 0.89 TGFBR1 (0.37) TGFBR1MAPK14THRBCYP1A2CYP2D6
SCHEMBL5200773 0.87 TGFBR1 (0.37) TGFBR1MAPK14THRBCYP1A2CYP2D6
SCHEMBL5198344 0.85 TGFBR1 (0.39) TGFBR1MAPK14THRBCYP1A2CYP2D6
SCHEMBL5198632 0.84 TGFBR1 (0.35) TGFBR1MAPK14THRBCYP1A2
SCHEMBL5199982 0.83 TGFBR1 (0.39) TGFBR1MAPK14THRBMEN1NPC1
SCHEMBL5201354 0.83 TGFBR1 (0.46) TGFBR1MAPK14THRB
SCHEMBL5200695 0.83 TGFBR1 (0.35) TGFBR1MAPK14THRB
SCHEMBL5198168 0.82 TGFBR1 (0.41) TGFBR1MAPK14THRBCYP1A2CYP2D6
SCHEMBL5200722 0.82 IRAK4 (0.41) TGFBR1MAPK14THRBMEN1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070275968-A1 Substituted Biphenyl Derivative SANKYO COMPANY, LIMITED (JP) 2007-11-29 US claimed
EP-1798229-A1 SUBSTITUTED BIPHENYL DERIVATIVE Sankyo Company, Limited (JP) 2007-06-20 EP claimed
US-20070275968-A1 Substituted Biphenyl Derivative SANKYO COMPANY, LIMITED (JP) 2007-11-29 US disclosed
EP-1798229-A1 SUBSTITUTED BIPHENYL DERIVATIVE Sankyo Company, Limited (JP) 2007-06-20 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070275968-A1 Substituted Biphenyl Derivative COL2A1, COL1A1, FGFR3 TGFBR1 40/4885MAPK14 2998/4885THRB 839/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.